Summary
Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
The global Capecitabine market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major End-Use
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
- Teva
- Roche
- Mylan
- Hikma
- Hengrui Medicine
- Cipla
- Reliance Group
- Hetero
Major applications as follows:
- Breast Cancer
- Colorectal cancer
- Stomach Cancer
Major Type as follows:
- 500 mg
- 150 mg
Regional market size, production data and export & import:
- Asia-Pacific
- North America
- Europe
- South America
- Middle East & Africa
Global Capecitabine Market Data Survey Report 2015-2025
Table of Contents
1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of End-Use
1.1.4 Scope of Product Type
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
Fig Global Capecitabine Market Size and CAGR 2015-2019 (Million USD)
Fig Global Capecitabine Market Size and CAGR 2015-2019 (Volume)
Fig Global Capecitabine Market Forecast and CAGR 2020-2025 (Million USD)
Fig Global Capecitabine Market Forecast and CAGR 2020-2025 (Volume)
2 Regional Market
2.1 Regional Sales
Tab Regional Sales Revenue 2015-2019 (Million USD)
Tab Regional Sales Volume 2015-2019 (Volume)
2.2 Regional Demand
Tab Regional Demand and CAGR List 2015-2019 (Million USD)
Tab Regional Demand and CAGR List 2015-2019 (Volume)
Tab Regional Demand Forecast and CAGR 2020-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2020-2025 (Volume)
2.3 Regional Trade
Tab Regional Export 2015-2019 (Million USD)
Tab Regional Export 2015-2019 (Volume)
Tab Regional Import 2015-2019 (Million USD)
Tab Regional Import 2015-2019 (Volume)
3 Key Manufacturers
3.1 Teva
3.1.1 Company Information
Tab Company Profile List of Teva
3.1.2 Product & Services
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Teva
3.1.4 Recent Development
3.2 Roche
3.2.1 Company Information
Tab Company Profile List of Roche
3.2.2 Product & Services
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Roche
3.2.4 Recent Development
3.3 Mylan
3.3.1 Company Information
Tab Company Profile List of Mylan
3.3.2 Product & Services
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Mylan
3.3.4 Recent Development
3.4 Hikma
3.4.1 Company Information
Tab Company Profile List of Hikma
3.4.2 Product & Services
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Hikma
3.4.4 Recent Development
3.5 Hengrui Medicine
3.5.1 Company Information
Tab Company Profile List of Hengrui Medicine
3.5.2 Product & Services
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Hengrui Medicine
3.5.4 Recent Development
3.6 Cipla
3.6.1 Company Information
Tab Company Profile List of Cipla
3.6.2 Product & Services
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Cipla
3.6.4 Recent Development
3.7 Reliance Group
3.7.1 Company Information
Tab Company Profile List of Reliance Group
3.7.2 Product & Services
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Reliance Group
3.8 Hetero
3.8.1 Company Information
Tab Company Profile List of Hetero
3.8.2 Product & Services
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Hetero
4 Major End-Use
4.1 Breast Cancer
4.1.1 Overview
Tab Summary of Consumption Distribution of Breast Cancer
4.1.2 Breast Cancer Market Size and Forecast
Fig Breast Cancer Market Size and CAGR 2015-2019 (Million USD)
Fig Breast Cancer Market Size and CAGR 2015-2019 (Volume)
Fig Breast Cancer Market Forecast and CAGR 2020-2025 (Million USD)
Fig Breast Cancer Market Forecast and CAGR 2020-2025 (Volume)
4.2 Colorectal cancer
4.2.1 Overview
Tab Summary of Consumption Distribution of Colorectal cancer
4.2.2 Colorectal cancer Market Size and Forecast
Fig Colorectal cancer Market Size and CAGR 2015-2019 (Million USD)
Fig Colorectal cancer Market Size and CAGR 2015-2019 (Volume)
Fig Colorectal cancer Market Forecast and CAGR 2020-2025 (Million USD)
Fig Colorectal cancer Market Forecast and CAGR 2020-2025 (Volume)
4.3 Stomach Cancer
4.3.1 Overview
Tab Summary of Consumption Distribution of Stomach Cancer
4.3.2 Stomach Cancer Market Size and Forecast
Fig Stomach Cancer Market Size and CAGR 2015-2019 (Million USD)
Fig Stomach Cancer Market Size and CAGR 2015-2019 (Volume)
Fig Stomach Cancer Market Forecast and CAGR 2020-2025 (Million USD)
Fig Stomach Cancer Market Forecast and CAGR 2020-2025 (Volume)
5 Market by Type
5.1 500 mg
5.1.1 Overview
Tab Product Overview of 500 mg
5.1.2 500 mg Market Size and Forecast
Fig 500 mg Market Size and CAGR 2015-2019 (Million USD)
Fig 500 mg Market Size and CAGR 2015-2019 (Volume)
Fig 500 mg Market Forecast and CAGR 2020-2025 (Million USD)
Fig 500 mg Market Forecast and CAGR 2020-2025 (Volume)
5.2 150 mg
5.2.1 Overview
Tab Product Overview of 150 mg
5.2.2 150 mg Market Size and Forecast
Fig 150 mg Market Size and CAGR 2015-2019 (Million USD)
Fig 150 mg Market Size and CAGR 2015-2019 (Volume)
Fig 150 mg Market Forecast and CAGR 2020-2025 (Million USD)
Fig 150 mg Market Forecast and CAGR 2020-2025 (Volume)
6 Price Overview
6.1 Price by Manufacturers
Tab Different Products Prices List of Major Manufacturers
6.2 Price by End-Use
Tab Different Products Prices List of End-Use
6.3 Price by Type
Tab Different Products Prices List of Produt Type
7 Conclusion
List of Tables
Tab Regional Sales Revenue 2015-2019 (Million USD)
Tab Regional Sales Volume 2015-2019 (Volume)
Tab Regional Demand and CAGR List 2015-2019 (Million USD)
Tab Regional Demand and CAGR List 2015-2019 (Volume)
Tab Regional Demand Forecast and CAGR 2020-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2020-2025 (Volume)
Tab Regional Export 2015-2019 (Million USD)
Tab Regional Export 2015-2019 (Volume)
Tab Regional Import 2015-2019 (Million USD)
Tab Regional Import 2015-2019 (Volume)
Tab Company Profile List of Teva
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Teva
Tab Company Profile List of Roche
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Roche
Tab Company Profile List of Mylan
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Mylan
Tab Company Profile List of Hikma
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Hikma
Tab Company Profile List of Hengrui Medicine
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Hengrui Medicine
Tab Company Profile List of Cipla
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Cipla
Tab Company Profile List of Reliance Group
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Reliance Group
Tab Company Profile List of Hetero
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Hetero
Tab Summary of Consumption Distribution of Breast Cancer
Tab Summary of Consumption Distribution of Colorectal cancer
Tab Summary of Consumption Distribution of Stomach Cancer
Tab Product Overview of 500 mg
Tab Product Overview of 150 mg
Tab Different Products Prices List of Major Manufacturers
Tab Different Products Prices List of End-Use
Tab Different Products Prices List of Produt Type
List of Figures
Fig Global Capecitabine Market Size and CAGR 2015-2019 (Million USD)
Fig Global Capecitabine Market Size and CAGR 2015-2019 (Volume)
Fig Global Capecitabine Market Forecast and CAGR 2020-2025 (Million USD)
Fig Global Capecitabine Market Forecast and CAGR 2020-2025 (Volume)
Fig Breast Cancer Market Size and CAGR 2015-2019 (Million USD)
Fig Breast Cancer Market Size and CAGR 2015-2019 (Volume)
Fig Breast Cancer Market Forecast and CAGR 2020-2025 (Million USD)
Fig Breast Cancer Market Forecast and CAGR 2020-2025 (Volume)
Fig Colorectal cancer Market Size and CAGR 2015-2019 (Million USD)
Fig Colorectal cancer Market Size and CAGR 2015-2019 (Volume)
Fig Colorectal cancer Market Forecast and CAGR 2020-2025 (Million USD)
Fig Colorectal cancer Market Forecast and CAGR 2020-2025 (Volume)
Fig Stomach Cancer Market Size and CAGR 2015-2019 (Million USD)
Fig Stomach Cancer Market Size and CAGR 2015-2019 (Volume)
Fig Stomach Cancer Market Forecast and CAGR 2020-2025 (Million USD)
Fig Stomach Cancer Market Forecast and CAGR 2020-2025 (Volume)
Fig 500 mg Market Size and CAGR 2015-2019 (Million USD)
Fig 500 mg Market Size and CAGR 2015-2019 (Volume)
Fig 500 mg Market Forecast and CAGR 2020-2025 (Million USD)
Fig 500 mg Market Forecast and CAGR 2020-2025 (Volume)
Fig 150 mg Market Size and CAGR 2015-2019 (Million USD)
Fig 150 mg Market Size and CAGR 2015-2019 (Volume)
Fig 150 mg Market Forecast and CAGR 2020-2025 (Million USD)
Fig 150 mg Market Forecast and CAGR 2020-2025 (Volume)
Global 5-Fluorouracil Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 76
The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030.
North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......
Global Carboplatin Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 79
The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......
Global Neutropenia Drugs Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 96
The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......
Global Small Molecule Cancer Drug Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......
Global Capecitabine Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 80
Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......
Global Oxaliplatin Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 104
Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely.
In this report, only The finished drug is covered, exclude API.
The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......
Global Cancer Treatment Drugs Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 158
According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period.
The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......
Global Capecitabine Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 93
According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period.
The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......
Global Methotrexate Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 95
According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period.
The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
